Calls for public funding for Continuous Glucose Monitors
Advocacy groups in New Zealand are calling for public funding of Continuous Glucose Monitors for patients with type 2 diabetes. A recent study suggests that earlier access to this technology could significantly reduce long-term health complications and improve patient longevity.
Why it matters
The debate over funding medical technology highlights the tension between healthcare costs and the goal of achieving equitable health outcomes for chronic disease patients.
A new study looks to why diabetic patients are so susceptible to heart problems (Getty Images). An advocacy charity would love Continuous Glucose Monitors to be funded for the thousands of Kiwis with type 2 diabetes.
A Waikato University Māori-led international study shows wider and earlier use of monitors, could help people live longer - and reduce risks of serious complications including blindness and kidney failure.
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in